Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 04, 2018

SELL
$2.48 - $3.21 $67,495 - $87,363
-27,216 Closed
0 $0
Q4 2017

Feb 05, 2018

SELL
$2.43 - $3.54 $19,231 - $28,015
-7,914 Reduced 22.53%
27,216 $72,000
Q3 2017

Nov 06, 2017

BUY
$2.22 - $3.2 $77,988 - $112,416
35,130
35,130 $112,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $526M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track First Eagle Investment Management, LLC Portfolio

Follow First Eagle Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Eagle Investment Management, LLC with notifications on news.